| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neogenomics Inc (NEO) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. NEO is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 176.4K | $1.58M | - | |
| COO | 143.8K | $1.29M | - | |
| Dir | 131.0K | $1.17M | - | |
| VP | 75.3K | $674.9K | - | |
| Dir | 44.0K | $394.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2019 | Cardoza George | President, Pharma Services | Sale+OE | 55,556 | $22.82 | $1,267,707.92 | -8.4% | |
| Nov 1, 2019 | Shovlin Robert J. | President, Clinical Services | Sale+OE | 106,274 | $22.99 | $2,442,745.77 | -24.5% | |
| Sep 10, 2019 | Jones Steven C | Director | Sell | 2,894 | $23.54 | $68,114.00 | - | |
| Aug 30, 2019 | Jones Steven C | Director | Sell | 40,737 | $25.02 | $1,019,215.74 | -1.2% | |
| Aug 28, 2019 | Bonello William | Chief Strategy Officer | Sale+OE | 17,000 | $24.83 | $422,110.00 | -71.6% | |
| Aug 27, 2019 | Jones Steven C | Director | Sell | 181,339 | $24.92 | $4,518,660.93 | -3.3% | |
| Aug 26, 2019 | Hipp Raymond R | Director | Sale+OE | 16,024 | $24.80 | $397,372.96 | -5.3% | |
| Aug 26, 2019 | Johnson Kevin C | Director | Sell | 53,000 | $25.41 | $1,346,652.00 | -43.7% | |
| May 8, 2019 | Hipp Raymond R | Director | Sell | 150,000 | $22.41 | $3,361,880.25 | -27.6% | |
| May 6, 2019 | Bonello William | Chief Strategy Officer | Sale+OE | 7,200 | $23.53 | $169,416.00 | -51.7% |